The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
qlt | 249 |
qlt plug delivery | 152 |
mati therapeutics | 87 |
dermira (canada) | 11 |
novartis | 11 |
3088922 | 9 |
novelion therapeutics | 8 |
qlt plug delivery, inc. - qpdi | 5 |
valeant pharmaceuticals internatio… 🛈 | 4 |
qlt usa | 3 |
mati therapeutics | 11 |
novelion therapeutics | 4 |
qlt plug delivery | 2 |
3088922 | 1 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
drug delivery methods, structures, and compositions for nasolacrimal system | 76 | 2006 |
drug cores for sustained release of therapeutic agents | 43 | 2007 |
therapeutic regimen and method for treating or ameliorating visual disorders associated … 🛈 | 34 | 2010 |
lacrimal implants and related methods | 33 | 2007 |
lacrimal implants and related methods | 26 | 2008 |
sustained release delivery of active agents to treat glaucoma and ocular hypertension | 23 | 2008 |
lacrimal implants and related methods | 23 | 2009 |
sustained released delivery of one or more agents | 23 | 2009 |
lacrimal implant detection | 22 | 2007 |
sustained release delivery of active agents to treat glaucoma and ocular hypertension | 21 | 2011 |